Completed
Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis
NCT00333034
- Conditions
- Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
- Locations
-
- Innsbruck, Austria
- Brussels, Belgium
- Leuven, Belgium
- Paris, France